Immunohistochemical study of CYP2E1 in hepatocellular carcinoma carcinogenesis: examination with newly prepared anti-human CYP2E1 antibody.
Cytochrome P450 2E1 (CYP2E1) is known as a heme-containing enzyme that produces abundant free radicals, and its involvement in carcinogenesis has been suggested in several organs in vivo. In this study, to clarify the involvement of CYP2E1 in liver cancer and its carcinogenesis process, we investigated the expression of CYP2E1 in 42 surgically resected or biopsied specimens of hepatocellular carcinomas (HCC) and 26 cases with other liver lesions immunohistochemically using a newly prepared anti-human CYP2E1 antibody. When intracellular CYP2E1 expression was investigated in three different regions of HCC specimens, the expression in hepatocytes of the peri-tumor region was the highest (p<0.001) compared with those in the tumor and non-peri-tumor regions. Histologically, the expression of CYP2E1 in tumor cells tended to decrease as the cells were less differentiated (p<0.0001) and was the lowest in poorly differentiated HCC (p<0.01). CYP2E1 expression was highest in the pseudo-glandular type and low in the thick trabecular and solid types of HCC (p<0.0001). In mature regenerative nodules of liver cirrhosis, adenomatous hyperplasia (AH) and atypical adenomatous hyperplasia (AAH) to early-HCC, CYP2E1 expression was notably high as compared with other legions. CYP2E1 has a strong free radical-producing ability, and the cell injury and DNA damages by the free radicals are considered to be involved in carcinogenesis. Therefore, our results suggest that the different expression of CYP2E1 in hepatocytes may play important roles in the multistep carcinogenic process and the histogenesis of hepatocellular carcinoma.
Hirose
Yoichiro
Y
Second Department of Pathology, Nippon Medical School, Japan.
Naito
Zenya
Z
Kato
Shunji
S
Onda
Masahiko
M
Sugisaki
Yuichi
Y
D000906:Antibodies / Q000276:immunology; D015153:Blotting, Western; D006528:Carcinoma, Hepatocellular / Q000201:enzymology* / Q000209:etiology; D019392:Cytochrome P-450 CYP2E1 / Q000096:biosynthesis* / Q000276:immunology; D006801:Humans; D007150:Immunohistochemistry; D008113:Liver Neoplasms / Q000201:enzymology* / Q000209:etiology
D000906:Antibodies; D019392:Cytochrome P-450 CYP2E1